Novo Nordisk’s Ozempic takes on Lilly’s Trulicity in DTC showdown
The two diabetes rivals air competing TV spots as they compete for GLP-1 supremacy.
The two diabetes rivals air competing TV spots as they compete for GLP-1 supremacy.
Matt McNally, CEO of Outcome Health, shares his thoughts on post-controversy Outcome Health and the overall state of the point-of-care union.
Among the group’s members are media agencies that had pulled healthcare ad spend from the POC channel in the wake of a scandal 10 months ago.
After a scandal with one of point of care’s biggest players, we examine how the community is living up to its promise of greater transparency.
Historical big earners once again performed for Pfizer in Q2, while Ibrance broke the $1 billion barrier.
The Truth Initiative surveyed 9,000 young people to determine whether its campaign was really working.
Data on medical education spending show a continued increase in investment from the pharma and medical device industries.
The company posted a sales increase of 10.6% in the second quarter.
The campaign is appearing in millennial- and women-focused outlets such as Refinery29, Instagram, Bravo!, HGTV, and Cosmopolitan.
Caregivers are intimately involved in patient health, and that includes deciding on treatments, a new study suggests.
Please login or register first to view this content.